Federal Trade Commission v. Mylan Laboratories
In this case, economists from Analysis Group worked closely with attorneys and economists at the Federal Trade Commission and 33 state attorneys general. Our task was to analyze issues of vertical restraint of trade and horizontal price fixing stemming from Mylan Laboratories' exclusive deal with an ingredient supplier for two anti-anxiety drugs.
Analysis Group supported Professors Ernst Berndt of MIT and Robert Hall of Stanford University in providing expert analyses related to both liability and damages. Professor Berndt conducted an in-depth study of competition and pricing in the generic pharmaceuticals market. Professor Hall, who handled the damages portion, performed an econometric analysis of generic drug pricing at the manufacturer level and a study of retail price mark-up. The $147 million settlement with Mylan Laboratories was the largest ever reached by the Federal Trade Commission in an anticompetition case.